Xylem (XYL) Raised to Buy at ValuEngine
Several other brokerages have also recently issued reports on XYL. Zacks Investment Research upgraded shares of Xylem from a “sell” rating to a “hold” rating in a report on Saturday, April 13th. Stifel Nicolaus increased their target price on shares of Xylem from $80.00 to $93.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. Boenning Scattergood reiterated a “buy” rating on shares of Xylem in a report on Friday, March 22nd. Janney Montgomery Scott cut shares of Xylem from a “buy” rating to a “neutral” rating in a report on Friday, March 29th. Finally, BMO Capital Markets reiterated a “buy” rating and set a $85.00 target price on shares of Xylem in a report on Monday, February 25th. One analyst has rated the stock with a sell rating, five have issued a hold rating and ten have assigned a buy rating to the stock. Xylem presently has an average rating of “Buy” and a consensus target price of $79.64.
NYSE XYL opened at $83.49 on Tuesday. The company has a current ratio of 1.51, a quick ratio of 1.08 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $14.85 billion, a PE ratio of 28.99, a P/E/G ratio of 1.43 and a beta of 1.14. Xylem has a 12 month low of $60.65 and a 12 month high of $83.55.
In other news, insider Kenneth Napolitano sold 35,526 shares of the firm’s stock in a transaction dated Monday, February 4th. The shares were sold at an average price of $70.17, for a total value of $2,492,859.42. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Tomas Brannemo sold 559 shares of the firm’s stock in a transaction dated Thursday, February 21st. The shares were sold at an average price of $74.44, for a total transaction of $41,611.96. Following the completion of the sale, the insider now owns 10,568 shares in the company, valued at $786,681.92. The disclosure for this sale can be found here. Insiders sold a total of 80,195 shares of company stock worth $6,000,933 over the last 90 days. Company insiders own 0.85% of the company’s stock.
Several large investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its position in Xylem by 3.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 2,083,342 shares of the industrial products company’s stock worth $166,396,000 after buying an additional 77,010 shares during the last quarter. Jane Street Group LLC acquired a new stake in shares of Xylem during the 3rd quarter worth approximately $997,000. Pacer Advisors Inc. grew its stake in shares of Xylem by 17.8% during the 3rd quarter. Pacer Advisors Inc. now owns 9,676 shares of the industrial products company’s stock worth $773,000 after purchasing an additional 1,464 shares during the period. AQR Capital Management LLC grew its stake in shares of Xylem by 39.2% during the 3rd quarter. AQR Capital Management LLC now owns 109,228 shares of the industrial products company’s stock worth $8,724,000 after purchasing an additional 30,737 shares during the period. Finally, Kentucky Retirement Systems acquired a new stake in shares of Xylem during the 3rd quarter worth approximately $527,000. Institutional investors and hedge funds own 86.64% of the company’s stock.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Featured Article: Outstanding Shares and The Effect on Share Price
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.